Research upholds use of supplements to slow macular degeneration

Ten years of data suggest that AREDS2 supplements are associated with a reduced risk of macular degeneration progression without any increase in lung cancer risk, according to a follow-up study published online June 2, 2022, by JAMA Ophthalmology.